Structure |
Chemical Name |
CAS |
MF |
|
Secondary Prostaglandin Metabolite LC-MS Mixture |
|
|
|
9ALPHA,15S-DIHYDROXY-11-OXO-PROST-13E-EN-1-OIC ACID |
17968-82-0 |
C20H34O5 |
|
Indoline |
496-15-1 |
C8H9N |
|
3-CYANOCOUMARIN |
15119-34-3 |
C10H5NO2 |
|
((1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5,6-dimethyl-6-(trimethylsilyloxy)hept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) |
2186604-89-5 |
C42H80O3Si3 |
|
Anti-Cyclooxygenase 3/Cox3 |
|
|
|
Ceftazidime and Avibactam Sodium for Injection |
|
|
|
13,14-DIHYDRO-15-KETO PROSTAGLANDIN D2 |
59894-07-4 |
C20H32O5 |
|
9-OXO-11ALPHA-15S-DIHYDROXY-PROSTA-5Z,13E-DIEN-1-OIC-3,3,4,4-D4 ACID |
34210-10-1 |
C20H28D4O5 |
|
4,7-DIHYDROXYCOUMARIN |
1983-81-9 |
C9H6O4 |
|
(9H-fluoren-9-yl)methyl (S)-(1-(methylamino)-1-oxo-5-ureidopentan-2-yl)carbamate |
|
|
|
(9H-fluoren-9-yl)methyl (S)-(4-methyl-1-(methylamino)-1-oxopentan-2-yl)carbamate |
|
|
|
(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline |
118864-75-8 |
C15H15N |
|
(2S,3R)-2-amino-3-methylpent-4-enamide |
2209873-96-9 |
C6H12N2O |
|
Carbamazepine intermediate |
|
|
|
(6R,7S)-Ceftriaxone Epimer |
|
|
|
(6β)-3-(1-Methyl-1H-tetrazole-5-ylthiomethyl)-7α-amino-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid benzhydryl ester |
66510-99-4 |
C24H24N6O5S |
|
tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate |
571188-59-5 |
C14H22N4O2 |
|
5-(1H-Pyrrol-1-yl)-2-mercaptobenzimidazole |
172152-53-3 |
C11H9N3S |
|
(1s-trans)-2-[(phenylmethoxy)methyl]-3-cyclopenten-1-ol |
188399-48-6 |
C13H16O2 |
|
(2S,4R)-4-BOC-AMINO PYRROLIDINE-2-CARBOXYLIC ACID METHYLESTER-HCL |
913742-54-8 |
C11H21ClN2O4 |
|
Methyl (R)-4,4-difluoropyrrolidine-2-carboxylate hydrochloride |
1408057-39-5 |
C6H10ClF2NO2 |
|
2-Cyanoethyl 3-oxobutanoate |
65193-87-5 |
C7H9NO3 |
|
Cefcanel |
41952-52-7 |
C19H18N4O5S3 |
|
(1S,2R,3S,5R)-2-(Benzyloxymethyl)-6-oxabicyclo[3.1.0]hexan-3-ol |
117641-39-1 |
C13H16O3 |
|
3,4-Diiodopyrazole |
6645-70-1 |
C3H2I2N2 |
|
4-Bromopyrazole |
2075-45-8 |
C3H3BrN2 |
|
Fendizoic acid |
84627-04-3 |
C20H14O4 |
|
Lysergamide, 1-acetyl-N,N-diethyl- (6CI,7CI) |
3270-02-8 |
C22H27N3O2 |
|
4-(4-Chloro-phenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid ethyl ester |
5948-71-0 |
C14H15ClN2O3 |
|
N2-Isobutyryl-2'-Fluoro-2'-deoxyguanosine |
80681-25-0 |
C14H18FN5O5 |
|
7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]- |
477600-73-0 |
C20H25N5 |
|
3-(1,1-diMethylethyl)-7a-ethenyltetrahydro-1-hydroxy-(3R,7aR)-3H,5H-Pyrrolo[1,2-c]oxazol-5-one |
1214741-21-5 |
C12H19NO3 |
|
(S)-1-(2-(1-aMino-2-Methylpropan-2-ylaMino)acetyl)pyrrolidine-2-carbonitrile dihydrochloride (AMino pyrrolidine) |
739364-93-3 |
C11H22Cl2N4O |
|
AMinopentaMide Sulfate |
20701-77-3 |
C19H26N2O5S |
|
(Ac)Phe-Lys(Alloc)-PABC-PNP |
|
C??H??N?O?? |
|
4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
170985-61-2 |
C37H42F2N8O4 |
|
Velpatasvir intermediate |
1378391-45-7 |
C44H53N7O7 |
|
Sodium 1-(2-hydroxyethyl)-1H-tetrazol-5-ylthiolate |
400827-72-7 |
C3H5N4NaOS |
|
(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate |
1187595-90-9 |
C22H27N7O4S |
|
(6R,7S)-Cefuroxime |
|
C16H16N4O8S |
|
(6-methyl-2-p-tolyl-2,3-dihydro-imidazo[1,2-a]pyridin-3-yl)-oxoacetic acid |
927820-48-2 |
C17H14N2O3 |
|
Triphenylsulfonium chloride |
4270-70-6 |
C18H15ClS |
|
5-GERANOXY-7-METHOXYCOUMARIN |
7380-39-4 |
C20H24O4 |
|
ACETIC ACID 2-PHENOXYETHYL ESTER |
6192-44-5 |
C10H12O3 |
|
ETHYL 1-HYDROXYCYCLOPENTANE-CARBOXYLATE |
41248-23-1 |
C8H14O3 |
|
Danshen injection intermediate |
|
|
|
Azacitidine Isomer |
|
|
|
6-FLUORO-4-HYDROXYCOUMARIN |
1994-13-4 |
C9H5FO3 |
|
Cefazolin Related Compound D |
|
|
|
Sugammadex sodium hexabromide intermediate |
|
|
|
(3S,5R,2R,3S)-posaconazole |
|
|
|
2',3',5'-TRI-O-BENZOYLINOSINE |
6741-88-4 |
C31H24N4O8 |
|
5-AMINO-2'-DEOXYURIDINE FREE BASE |
5536-30-1 |
C9H13N3O5 |
|
(R)-3-Aminopentanoic acid |
131347-76-7 |
C5H11NO2 |
|
Methanesulfonic anhydride |
370071-69-5 |
C8H6Br4O2 |
|
Olmesartan intermediate |
|
|
|
(1R,3R)-Methyl-1,2,3,4-tetrahydro-2-chloroacetyl-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate |
|
C22H18ClN2O5- |
|
L-Inosine |
21138-24-9 |
C10H12N4O5 |
|
1H-Pyrrolizine-7a(5H)-carboxylicacid,tetrahydro-,methylester(9CI) |
117375-15-2 |
C9H15NO2 |
|
5-iodo-1-(2-fluoro-2-deoxyribofuranosyl)uracil |
55612-21-0 |
C9H10FIN2O5 |
|
5-(Difluoromethoxy)-2[[(4-chloro-3-methoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole |
368890-20-4 |
C15H12ClF2N3O2S |
|
Morpholin-2-yl-methylamine |
116143-27-2 |
C5H12N2O |
|
3-AMINO-8-BENZYL-8-AZABICYCLO[3.2.1]OCTANE (3-EXO)- |
76272-36-1 |
C14H20N2 |
|
7-Fluoroindole |
387-44-0 |
C8H6FN |
|
N-Benzoyl-5'-O-(4,4-Dimethoxytrityl)-2'-O-[(tert-butyl)dimethylsilyl]adenosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite |
104992-55-4 |
C53H66N7O8PSi |
|
(S)-(2-Aminomethyl)-1-N-Boc-pyrrolidine HCl |
1190890-11-9 |
C10H21ClN2O2 |
|
3',5'-di-o-acetyl-2-deoxy-5-azacytosine |
22432-93-5 |
C12H16N4O6 |
|
(2S,4S)-1-(tert-Butoxycarbonyl)-4-fluoro-2-hydroxymethylpyrrolidine |
317356-27-7 |
C10H18FNO3 |
|
(S)-2-(((3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoic acid methyl ester hydrochloride |
170098-28-9 |
C24H31NO3.HCl |
|
4a,5,9,10,11,12-hexahydro-1-bromo-3-methoxy-11-formyl-6H-benzofuro[3a,3,2-ef
][2]benzazepin-6-one |
122584-14-9 |
C17H16BrNO4 |
|
TF-BF |
209861-00-7 |
C24H22F2O5 |
|
Cefaclor, Delta-3 IsoMer |
|
|
|
N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride |
1260590-51-9 |
C13H20ClN5 |
|
tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl]carbaMate |
1172623-99-2 |
C16H21F2NO4 |
|
N,N-Diphenyl-1H-imidazole-1-carboxamide |
2875-79-8 |
C16H13N3O |
|
Coumarin |
10172-76-6 |
C27H21NO6 |
|
Pemetrexed intermediate |
|
|
|
(2S,5S)-ethyl 5-methylpyrrolidine-2-carboxylate 2,2,2-
trifluoro acetate salt |
676560-85-3 |
C10H16F3NO4 |
|
,100kg |
180048-73-1 |
C11H14O4S |
|
1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydrochloride |
156077-56-4 |
C12H29ClN4O3 |
|
tert-butyl 4-(4-bromothiazol-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate |
1332301-87-7 |
C13H17BrN2O2S |
|
PPAP |
784118-64-5 |
C14H23N |
|
Cefmetazole Impurity 4 |
68576-47-6 |
C15H17N7O4S4 |
|
Otilonium Bromide intermediates |
51444-79-2 |
C22H27NO4 |
|
(5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-5-phenyl-2-pyrrolidinone |
1027552-46-0 |
C21H22FNO3 |
|
4F-MPH |
1354631-33-6 |
C14H18FNO2 |
|
2-Isopropoxy-5-methyl-4-(piperidin-4-yl)aniline dihydrochloride hydrate |
1802250-63-0 |
C15H27ClN2O2 |
|
Oseltamivir-13CD3 |
1093851-61-6 |
C16H28N2O4 |
|
tert-butyl (3R,4S,5S)-4-((S)-2-amino-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoate |
177423-00-6 |
C19H38N2O4 |
|
tert-butyl 6-bromo-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-1-carboxylate |
1403901-49-4 |
C14H19BrN2O2 |
|
2H-1-Benzopyran-2-one, 6-chloro-4-methyl- |
24145-78-6 |
C10H7ClO2 |
|
4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylbenzoic acid |
864725-62-2 |
C18H12Cl2F3NO3 |
|
-- |
93360-08-8 |
C30H27N2O6P |
|
Tadanafil intermediate (chloroacetyl porphyrin) |
171596-59-1 |
C31H57BN4O6Si |
|
6-BROMO-4-HYDROXYCOUMARIN |
4139-61-1 |
C9H5BrO3 |
|
ETHYL 5-ISOPROPYL-3-METHYLISOXAZOLE-4-CARBOXYLATE |
357326-79-5 |
C10H15NO3 |
|
4S-fluoropyrrolidine-2R-carboxylic acid methyl ester hydrochloride salt |
131176-03-9 |
C6H11ClFNO2 |
|
LOXO-292 |
2222755-14-6 |
C29H31N9O3 |
|
1-Piperazinecarboxylic acid, 2-methyl-5-[[(3R)-3-methyl-4-morpholinyl]methyl]-, 1,1-dimethylethyl ester, (2R,5S)- |
1403902-78-2 |
C16H31N3O3 |